ADUS in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with ADUS today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Addus HomeCare Corp. sends caregivers to help older adults and people with chronic illnesses or disabilities with everyday tasks such as bathing, eating and preparing meals. This non-medical personal care generates most of its revenue. It also provides hospice care for terminally ill patients and their families, and a smaller home health business supplies nursing and rehabilitation during recovery from illness or hospitalization.
Government programs, including Medicaid and Medicare, and managed care organizations pay for nearly all its services. Addus delivers care and then seeks reimbursement; government agreements commonly pay by the hour or unit of service. The Illinois Department on Aging is a significant payer for personal care, making the company particularly dependent on that agency’s authorized services and funding.
The business depends on recruiting enough caregivers and keeping service costs within reimbursement rates. Personal care payers determine who qualifies, how much care is authorized and what they will pay under applicable laws and contracts. Government funding and payment rates therefore shape both service volume and profitability. Medicare also caps hospice reimbursement, requiring Addus to repay payments above those limits.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Aveanna Healthcare Holdings Inc. and Addus both depend on Medicaid funding and the availability and cost of home-care workers, while competing to provide medical care at home and hospice care. Watch Aveanna’s news on Medicaid reimbursement and staffing for pressures that also reach Addus.
The Pennant Group, Inc. competes with Addus for patients, referrals and caregivers in overlapping markets, offering nursing and therapy at home, hospice care and help with daily living. Pennant receives payment from Medicare, Medicaid, managed-care payors and private-paying patients; watch its home-care operations rather than its senior living business for the closer comparison with Addus.
BrightSpring Health Services, Inc. competes with Addus in home health, hospice and supportive care for patients with complex medical needs, serving populations covered by Medicare, Medicaid and commercial insurance. Watch its care-services business separately from its substantial medication-dispensing and pharmacy-support operations when comparing it with Addus.
Chemed Corporation competes with Addus through VITAS, which provides hospice and palliative care to terminally ill patients. VITAS is the business to watch for the hospice comparison, not Chemed’s unrelated Roto-Rooter plumbing and drain-cleaning services for households and businesses.
National Healthcare Corp.’s homecare and hospice agencies compete with Addus, but its nursing facilities, senior living facilities and behavioral health hospitals make the overall business a less direct comparison. Focus on its homecare and hospice operations, primarily in the Southeastern and Midwestern United States, rather than facility-based results.
Chemed Corporation earningsCHE
Chemed’s VITAS business provides hospice care, and its report will show how patient demand and referrals are developing in a market it shares with Addus HomeCare.
Read VITAS’s patient census alongside revenue per patient day. Growth in both would point to firm hospice demand and revenue per patient, a supportive market signal for Addus’s hospice business, though VITAS remains a competitor for patients and referrals. Weakness in either would raise the question of whether Addus also faces more difficulty sustaining its census or revenue. The report helps distinguish a strong hospice market from added competitive pressure.
Fed Interest Rate Decision
Addus HomeCare’s interest-rate exposure runs through its $124.3 million of credit-facility debt: the Fed’s policy rate influences borrowing costs, which affect interest expense and earnings.
Expected4.0%Last release4.0%
If it comes in above expectations
If the Fed sets rates higher than expected, borrowing costs may rise; that could increase interest expense on debt that reprices or on new borrowing and reduce earnings.
If it comes in below expectations
If the Fed sets rates lower than expected, borrowing costs may ease; that could reduce interest expense on debt that reprices or on new borrowing and support earnings.
Addus HomeCare Corp. earningsThis company
Addus HomeCare earns most of its revenue from personal care, and this report will show whether revenue per hour and margins are keeping pace with growth in service hours.
Read personal-care billable hours alongside revenue per billable hour and the segment’s operating margin. More hours with revenue per hour and margin holding would show that added care is turning into profitable growth. If hours rise but revenue per hour or margin falls, reimbursement or caregiver costs are absorbing the gain. The test is whether growth in service hours brings profit, not just more services.
JOLTs Job Openings (Sep)
Addus HomeCare’s in-home personal care, hospice and home health services depend on caregivers and skilled staff, so job openings track hiring demand that can affect competition for workers and wage costs.
Expected7.0MLast release7.079M
If it comes in above expectations
More openings than expected point to stronger hiring demand and tighter competition for caregivers and skilled staff, which could push up Addus HomeCare’s wages and operating costs.
If it comes in below expectations
If the reading is below the 7.0M estimate, it is below the previous 7.079M. Fewer openings than expected point to looser hiring demand and potentially less competition for caregivers and skilled staff, which could ease wage and operating-cost pressure.
The Pennant Group, Inc. earningsPNTG
The Pennant Group’s home-care business competes with Addus for patients, referrals and caregivers, and its report will show whether growth in that shared market is straining margins.
Read growth in Pennant’s home-care operations alongside their profitability, leaving its senior-living business out of the comparison. Growth with profits holding would suggest that demand and caregiver availability are supporting expansion in overlapping markets. Growth with weaker profits would point to labor or payor costs squeezing the economics of care, making it harder for Addus to recruit caregivers and protect margins. The question is whether a competitor can expand home care without costs eroding its returns.
Aveanna Healthcare Holdings Inc. earningsAVAH
Aveanna and Addus both depend on Medicaid funding and home-care workers, so Aveanna’s report can show how reimbursement and staffing pressures are affecting home-based care.
Watch Aveanna’s comments on Medicaid reimbursement, caregiver availability and staffing costs in its home-care services. Reimbursement keeping pace with labor costs, with workers available, would suggest the shared pressures on Addus may be manageable. Rates lagging costs while staffing remains difficult would point to greater strain on margins and the ability to serve patients. The key is whether payor revenue covers the labor needed to provide home care.
Non Farm Payrolls (Oct)
Addus HomeCare’s in-home personal care, hospice and home health services rely on caregivers and skilled staff, so payroll growth tracks hiring that can intensify competition for workers and raise wages.
Stronger payroll growth suggests hiring demand may tighten the market for Addus HomeCare’s caregivers and skilled staff, adding wage pressure; weaker growth suggests that pressure may ease.